Tesamorelin
Product Name: Tesamorelin Research Category: Growth Hormone-Releasing Hormone (GHRH) Analog Alternative Name: TH9507 CAS Number: 218949-48-5 Molecular Formula: C221H366N72O67S Molecular Weight: Approximately 5,135.9 g/mol Peptide Type: Synthetic GHRH analog Appearance: Typically supplied as a white to off-white lyophilized peptide powder. Research Interest: Growth hormone signaling, IGF-1 regulation, body composition, adipose tissue metabolism, and endocrine research. Description
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It interacts with GHRH receptors in the pituitary gland and stimulates the endogenous release of growth hormone. It has been investigated extensively in research involving growth hormone signaling, body composition, and adipose tissue metabolism. Mechanism of Research
Tesamorelin acts as an agonist at GHRH receptors, stimulating pulsatile secretion of endogenous growth hormone and subsequently influencing insulin-like growth factor-1 (IGF-1). Research focuses on the downstream metabolic and body-composition effects associated with the GH/IGF-1 axis. Storage
Storage requirements depend on the formulation and supplier. Material should be stored according to the accompanying certificate of analysis (COA), product specification sheet, and manufacturer instructions. Research Use Disclaimer
Product status and approved uses vary by jurisdiction and formulation. This information is provided for scientific reference purposes and is not medical, prescribing, or dosing advice. 
